Observational Study Describing Conditions for Intensification of Insulin Therapy in Type 2 Diabetes
- Registration Number
- NCT00712478
- Lead Sponsor
- Novo Nordisk A/S
- Brief Summary
This study is conducted in Europe. The aim of this observational study is to determine diabetes control improvement, during the third month of follow-up after insulin intensification to at least 3 daily insulin injections, in assessing the proportion of uncontrolled fasting and postprandial glycaemia values recorded on a diary.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 114
Inclusion Criteria
- Type 2 diabetes patients
- Treatment with two insulin daily injections and needing insulin intensification regimen to at least three daily injections
- HbA1c greater than or equal to 8.0%
Exclusion Criteria
- Patients not performing glycaemia self-measurements
- Secondary diabetes
- Requirement of or use of an insulin pump
- Treatment with corticoids
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description A insulin -
- Primary Outcome Measures
Name Time Method Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements After 3 months
- Secondary Outcome Measures
Name Time Method Evaluate improvement of diabetes control with fasting glycemia and after diner glycemia measurements After first 2 months